Provided by Tiger Trade Technology Pte. Ltd.

KINTOR PHARMA-B

2.650
+0.0200.76%
Volume:161.50K
Turnover:432.06K
Market Cap:1.32B
PE:-7.35
High:2.790
Open:2.790
Low:2.650
Close:2.630
52wk High:3.150
52wk Low:0.860
Shares:499.00M
HK Float Shares:499.00M
Volume Ratio:0.94
T/O Rate:0.03%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.361
ROE:-54.99%
ROA:-17.21%
PB:5.43
PE(LYR):-7.35
PS:106.79

Loading ...

Qinghai Implements Multiple Measures to Promote Traditional Chinese and Tibetan Medicine Innovation

Deep News
·
8 hours ago

BIOSTAR PHARM-B Receives CSRC Filing Notice for Full Circulation of H Shares

Stock News
·
Feb 06

Tasly Pharmaceutical Reports 11.05 Billion Yuan Net Profit for 2025, Marking 15.68% Year-on-Year Growth

Stock News
·
Feb 06

TYK MEDICINES-B's New Drug Application for TY-9591 Tablets Accepted by Regulatory Authority

Stock News
·
Feb 06

TYK MEDICINES-B Shares Surge Nearly 5% in Afternoon Session as Key Drug Gains Priority Review Status

Stock News
·
Feb 06

Great Wall Fund's Healthcare Investment Team Maintains Optimism on Medical Technology and Seeks New Rationale for Innovative Drugs

Deep News
·
Feb 05

BOCOM International Forecasts Continued Stable Growth for Healthcare Sector This Year, Recommends Seeking Undervalued Stocks

Stock News
·
Feb 05

Healthcare Sector Demonstrates Resilience as Traditional Chinese Medicine Leaders Lead Gains, While Exclusive Pharmaceutical ETF Defies Market Downturn

Deep News
·
Feb 05

OpenAI Explores New Revenue Streams in Pharma: Plans "Investment Plus Royalty" Model to Target AI-Driven Biotech Innovation

Stock News
·
Feb 04

32 New Funds Launched This Week: 27 Firms Including GF and E Fund Compete Across Battery, AI, Healthcare, and Gold Sectors, Some Products Already Closed Early

Deep News
·
Feb 03

Hubei Jumpcan Pharmaceutical (600566.SZ) Subsidiary Signs Exclusive Commercialization Agreement with Puqi Pharmaceutical

Stock News
·
Feb 02

KINTOR PHARMACEUTICAL LIMITED (09939) Announces Monthly Return as of January 31, 2026

Bulletin Express
·
Feb 02

283 Healthcare Stocks Preview 2025 Performance: Top Forecast Shows Over 32-Fold Increase, 39 Stocks Including Zhifei Biological Report First Loss

Deep News
·
Feb 01

New Stock Alert | Xinji Pharmaceutical, Yifei Technology Among Companies With Hong Kong IPO Applications Accepted by China Securities Regulatory Commission

Stock News
·
Jan 30

Yan'an Pharma's Second Attempt at BSE Listing: Strained Cash Flow, Persistent Margin Pressure, and Governance Concerns Draw Regulatory Scrutiny

Deep News
·
Jan 30

Renfu Pharmaceutical Claim Submission Filed for Registration, Eligible Investors Can Register

Deep News
·
Jan 30

Hong Kong Stock Movement | TYK MEDICINES-B (02410) Surges Over 13% in Morning Session as Aimdotinib Mesylate Tablets Included in Priority Review List

Stock News
·
Jan 30

TYK MEDICINES-B (02410) Has Its Investigational Class 1 New Drug, Aidosertinib Mesylate Tablets, Included in the CDE's Priority Review List

Stock News
·
Jan 29

China Galaxy Securities: Bullish on Pharma's Earnings Certainty, Innovation, and Overseas Expansion; Sector Poised for Rebound in 2026

Stock News
·
Jan 29

Over 10 Companies Queue for Hong Kong Listings, "A+H" Emerges as New Choice for Pharma IPOs - Why Are A-Share Drugmakers Flocking to HK?

Deep News
·
Jan 29